WASHINGTON, DC - AUGUST 01: Protect Our Care host a lite-brite display outside of Pharma headquarters urging Congress to "Fight Pharma: Lower Rx Prices Now!" on August 01, 2022 in Washington, DC. (Photo by Paul Morigi/Getty Images for Protect Our Care)

WASHINGTON (AP) — Democrats say the Senate parliamentarian has narrowed the party’s plan for curbing drug prices but left it largely intact. It’s an important win overall for Democrats as they prepare to start moving their sprawling economic bill through the chamber, but also a setback on the drug-pricing issue. Parliamentarian Elizabeth MacDonough is the Senate’s rules arbiter. Democrats say she’s decided that provisions must be removed that would force drugmakers to pay rebates if their prices rise above inflation for products they sell to private insurers. But other major provisions have survived, such as letting Medicare negotiate prices for the drugs it buys and limiting seniors’ out-of-pocket costs.